» Authors » Mikael Lehtihet

Mikael Lehtihet

Explore the profile of Mikael Lehtihet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 241
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Heiland C, Lehtihet M, Borjesson A, Ekstrom L
Drug Test Anal . 2024 Feb; 16(11):1319-1322. PMID: 38320573
Recombinant human erythropoietin (rhEPO) has been abused as a performance enhancer in sports for several years, but with advancements in detection methods, even micro-doses can be detected in dried blood...
2.
Borjesson A, Ekebergh M, Dahl M, Ekstrom L, Lehtihet M, Vicente V
Int J Qual Stud Health Well-being . 2023 Dec; 19(1):2292826. PMID: 38085771
Purpose: Anabolic androgenic steroids (AAS) are used for their aesthetic and performance-enhancing effects and are associated with physical and psychological side effects. Behavioural changes/side effects as mood swings, aggressiveness, depression,...
3.
Makvandi B, Pohanka A, Bergstrom M, Borjesson A, Lehtihet M, Ekstrom L, et al.
Drug Test Anal . 2023 Mar; 15(6):678-688. PMID: 36987780
When testing for anabolic androgenic steroids (AAS) outside sports communities, for example, in healthcare and forensic medicine, urine is the matrix of choice. However, there are drawbacks with urinary sampling,...
4.
Heiland C, Schickel Y, Lehtihet M, Borjesson A, Ekstrom L
Drug Test Anal . 2023 Feb; 15(6):599-604. PMID: 36730044
Hematological parameters and erythropoiesis are known to be influenced by anabolic androgenic steroid (AAS) use. However, little is known in relation to supra-physiological doses of AAS. Therefore, the aim of...
5.
Lehtihet M, Stephanou C, Borjesson A, Bhuiyan H, Pohanka A, Ekstrom L
Front Sports Act Living . 2022 Apr; 4:829940. PMID: 35434614
It has been suggested to longitudinally monitor Insulin-like growth factor I (IGF-I) as a biomarker for the detection of recombinant growth hormone (GH). Subsequently, it is of interest to understand...
6.
Borjesson A, Ekebergh M, Dahl M, Ekstrom L, Lehtihet M, Vicente V
Front Sports Act Living . 2021 Dec; 3:656413. PMID: 34859201
Anabolic androgenic steroids are used by women to increase their muscle mass and because of their performance-enhancing effects. Despite permanent/high risk of side effects, knowledge is inadequate. Our aim has...
7.
Borjesson A, Ekebergh M, Dahl M, Ekstrom L, Lehtihet M, Vicente V
Int J Qual Stud Health Well-being . 2021 May; 16(1):1927490. PMID: 34006211
: Anabolic androgenic steroids (AAS) are used by men for their aesthetic and performance-enhancing effects and are associated with risk for side effects. Our research aims to deepen knowledge and...
8.
Andersson D, Landucci L, Trolle Lagerros Y, Grotta A, Bellocco R, Lehtihet M, et al.
J Am Coll Cardiol . 2021 Mar; 77(12):1535-1550. PMID: 33766260
Background: Phosphodiesterase 5 inhibitor (PDE5i) treatment is associated with reduced mortality compared with no treatment for erectile dysfunction after myocardial infarction (MI). Objectives: This study sought to investigate the association...
9.
Ericsson M, Bhuiyan H, Yousif B, Lehtihet M, Ekstrom L
Drug Test Anal . 2020 Oct; 12(11-12):1620-1628. PMID: 33125822
The intra-individual stability of growth hormone (GH) biomarkers IGF-I, P-III-NP, calculated GH-2000 score in relation to growth hormone-releasing hormone (GHRH) (Somatorelin) administration, menstrual cycle, and hematological parameters were investigated in...
10.
Borjesson A, Moller C, Hagelin A, Vicente V, Rane A, Lehtihet M, et al.
Medicina (Kaunas) . 2020 Jun; 56(6). PMID: 32481676
Anabolic androgenic steroids (AAS) are mainly used for aesthetic and performance-enhancing reasons. Their use is a growing public health problem and concern for society because of their adverse effects. The...